XETRA:BAYN

Bayer Aktiengesellschaft · XETRA · Healthcare · EUR · FY for 2025

Figures on this page computed 2026-11-08 00:40 UTC

Last close

n/aEUR

Market data

We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-07
Reported in
EUR
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
-7.9%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
4.6%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
1.44Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
0.2%Dividend yield
Source
computed
Taken on
2026-11-07
Reported in
EUR
- computed

Safety is the furthest below its sector's middle: 0.31 against 0.57 on the market's range.

Five bars, one line

lens 7 of 9

1.07x

-11.33x

0.50x

1.05x

n/a

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Computed2025

Market datan/a

Each against its own average

4 of 5 read

Except where said otherwise: Computed from the filing for 2025

Sales1.07x
Its own average over 10 years, 42.63B.
Profit-11.33x
Its own average over 10 years, 319.5M.
Free cash flow0.50x
Its own average over 10 years, 4.13B.
Debt1.05x
Its own average over 10 years, 35.67B.
Pricen/a
Its own average over 0 years. Market data

Profit is furthest from its own average, at -11.33 times.

The filed years, as a table

Each line is 100 at 2016-12-31, the first year we hold.

Filed year	Sales	Profit	Shares in issue
2016-12-31	100.0	100.0	100.0
2017-12-31	100.2	161.9	104.8
2018-12-31	105.1	37.4	111.2
2019-12-31	124.6	90.3	116.0
2020-12-31	118.5	-231.6	116.1
2021-12-31	126.2	22.1	116.1
2022-12-31	145.2	91.6	116.1
2023-12-31	136.3	-64.9	116.1
2024-12-31	133.4	-56.3	116.1
2025-12-31	130.4	-79.9	116.1

How sales was got

Source: computed
Statement: income
Fiscal year: 2025
Reported in: EUR

How profit was got

Source: computed
Statement: income
Fiscal year: 2025
Reported in: EUR

How shares in issue was got

Source: computed
Statement: income
Fiscal year: 2025
Reported in: EUR

Figures behind the shape

Growth

1.9%

faster is higher, placed against 4,950 companies as of 2026-11-07

Five-year revenue growth rate1.9%
Source
computed
Taken on
2026-11-07
Reported in
EUR
- computed
Five-year EPS growth raten/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
EUR
- computed
One-year change in net income-41.9%
Source
computed
Taken on
2026-11-07
Reported in
EUR
- computed

Returns on capital

-13.9%

higher is higher, placed against 5,089 companies as of 2026-11-07

Return on invested capitaln/a
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on equity-13.9%
Net Income / Shareholders' Equity x 100
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on assets-3.3%
Net Income / Total Assets x 100
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025

Margins

59.2%

wider is higher, placed against 3,412 companies as of 2026-11-07

Gross margin59.2%
Gross Profit / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Operating margin15.3%
Operating Income / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Net margin-7.9%
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Free cash flow margin4.6%
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025

Price

2.1x

cheaper is higher, placed against 4,362 companies as of 2026-11-07

Price to earningsn/a
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-07
Reported in
EUR
- computed
- Computed from the filing for 2025
Price to book2.1x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
Source
computed
Taken on
2026-11-07
Reported in
EUR
- computed
- Computed from the filing for 2025
- computed
- Computed from the filing for 2025
EV to EBITDA32.2x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
Source
computed
Taken on
2026-11-07
Reported in
EUR
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Price to sales ratio1.2x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
Source
computed
Taken on
2026-11-07
Reported in
EUR
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025

Safety

1.44

safer is higher, placed against 3,227 companies as of 2026-11-07

Debt to equity1.44
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Current ratio1.00
Current Assets / Current Liabilities
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Interest coverage4.0x
Operating Income / Interest Expense
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Altman Z-Score1.09
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025

What it pays out

0.2%

more, and better covered, is higher, placed against 1,091 companies as of 2026-11-07

Dividend yield0.2%
Source
computed
Taken on
2026-11-07
Reported in
EUR
- computed
Payout ration/a
We do not hold this figure for this company, so there is nothing to place.
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
Source
computed
Taken on
2026-11-07
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Dividend cover ratio16.4x
Source
computed
Taken on
2026-11-07
Reported in
EUR
- computed

Share a finding

A link to the finding, not to you: it carries nothing about your account.